Did you know that your gut bacteria might predict whether or not you will respond to immunotherapy? Three different studies have found that responders and non-responders can be predicted based on the composition of their intestinal microbiota.1
What do the studies show?
One of the studies, conducted by Laurence Zitvogel at the Institut Gustave Roussy, Villejuif, Paris, looked specifically at immunotherapy response by those with non-small cell lung cancer and renal cell carcinoma. The study found that patients with more bacteria from the species Akkermansia muciniphila had the best response to anti-PD-1 therapy.